Recordati establishes Canadian presence with launch of Recordati Rare Diseases Canada Inc.

Thursday, April 13, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

TORONTO, April 13, 2017 /CNW/ - Recordati, a global biopharmaceutical company committed to providing orphan therapies to

underserved rare disease communities, today announced the incorporation of its Canadian affiliate, Recordati Rare Diseases Canada Inc.

Recordati Rare Diseases Canada, a company wholly owned by the Italy-based

Recordati Group, will be the exclusive provider of several treatments, including CarbagluŽ (carglumic acid), CystadaneŽ (betaine anhydrous) and CosmegenŽ (dactinomycin) in Canada.

"We're thrilled to be a part of Canada's innovative biopharmaceutical community focused on bringing treatments to ultra-rare disease and oncology patients" said Paul McCabe, General Manager, Recordati Rare Diseases Canada. "As a company, we're happy to be able to bring these products together under one umbrella to offer the highest-quality treatments to these patients."

Based in Toronto, Recordati has launched a new website designed to assist Canadians with certain rare diseases across the country. For more, visit www.recordatirarediseases.ca.

About Recordati Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange with a total staff of around 4,100, dedicated to the research, development, manufacturing and marketing of pharmaceuticals, notably those indicated for the treatment of rare diseases.

Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa, in the United States of America and in some Latin American countries.

 

SOURCE Recordati



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store